Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -10625.29% is 205% below its 1-year average of -3482.08%, near the low end of its 1-year range (-10625.29%–-490.80%).
205.14% below its 12-month average of -3482.08%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2025 (2025-12-31): -3064.00%.
EBITDA MARGIN
-10625.29%
EBITDA MARGIN AVG TTM
-3482.08%
EBITDA MARGIN AVG 3Y
-3482.08%
EBITDA MARGIN AVG 5Y
-3482.08%
EBITDA MARGIN AVG 10Y
-37322.37%
EBITDA MARGIN AVG 15Y
-233.17%
EBITDA MARGIN AVG 20Y
-2823.56%
CURRENT VS TTM AVG
-205.14%
CURRENT VS 3Y AVG
-205.14%
CURRENT VS 5Y AVG
-205.14%
CURRENT VS 10Y AVG
+71.53%
CURRENT VS 15Y AVG
-4456.80%
CURRENT VS 20Y AVG
-276.31%
Lisata Therapeutics, Inc.
Market Cap
$11.06M
EBITDA Margin
-10625.29%
TTM Avg
-3482.08%
3Y Avg
-3482.08%
5Y Avg
-3482.08%
Market Cap
$11.02M
EBITDA Margin
-284.92%
TTM Avg
-261.31%
3Y Avg
-2315.78%
5Y Avg
-2461.07%
Market Cap
$11.12M
EBITDA Margin
28.31%
TTM Avg
28.31%
3Y Avg
28.31%
5Y Avg
-18969.31%
Market Cap
$10.82M
EBITDA Margin
-133689.80%
TTM Avg
-133689.80%
3Y Avg
-133689.80%
5Y Avg
-133689.80%
Market Cap
$11.23M
EBITDA Margin
-5625.93%
TTM Avg
-8506.17%
3Y Avg
-6687.48%
5Y Avg
-5181.84%
Market Cap
$11.53M
EBITDA Margin
-42476.19%
TTM Avg
-23876.87%
3Y Avg
-47050.54%
5Y Avg
-38398.83%
Market Cap
$10.59M
EBITDA Margin
-2404.23%
TTM Avg
-2020.23%
3Y Avg
-5031.76%
5Y Avg
-7490.37%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lisata Therapeutics, Inc. (LSTA) | $11.06M | -10625.29% | -3482.08% | -3482.08% | -3482.08% |
| Cerenome, Inc. (CNSY)vs › | $11.02M | -284.92% | -261.31% | -2315.78% | -2461.07% |
| BioVie Inc. (BIVI)vs › | $11.09M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | 28.31% | 28.31% | 28.31% | -18969.31% |
| Caring Brands, Inc. (CABR)vs › | $10.82M | -133689.80% | -133689.80% | -133689.80% | -133689.80% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.11M | N/A | N/A | N/A | N/A |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.23M | -5625.93% | -8506.17% | -6687.48% | -5181.84% |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.53M | -42476.19% | -23876.87% | -47050.54% | -38398.83% |
| Pluri Inc. (PLUR)vs › | $10.59M | -2404.23% | -2020.23% | -5031.76% | -7490.37% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.59M | -273136.36% | -273136.36% | -93106.62% | -57343.52% |
Gross Margin
14.1%
EBITDA Margin
-10625.3%
Operating Margin
-10711.2%
Net Margin
-14621.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2025-12-31 | -3064.00% |
| 2025-06-30 | -6891.43% |
| 2024-12-31 | -490.80% |
| 2017-12-31 | -361600.20% |
| 2017-03-31 | -72.92% |
| 2016-12-31 | -51.75% |
| 2016-09-30 | -54.28% |
| 2016-06-30 | -80.97% |
| 2016-03-31 | -138.01% |
| 2015-12-31 | -779.30% |
| 2015-09-30 | -165.49% |
| 2015-06-30 | -426.44% |
| 2015-03-31 | -551.18% |
| 2014-12-31 | -283.20% |
| 2014-09-30 | -380.46% |
| 2014-06-30 | -264.80% |
| 2014-03-31 | -321.86% |
| 2013-12-31 | -247.36% |
| 2013-09-30 | -529.47% |
| 2013-06-30 | -181.05% |
| 2013-03-31 | -327.89% |
| 2012-12-31 | -274.56% |
| 2012-09-30 | -173.73% |
| 2012-06-30 | -190.43% |
| 2012-03-31 | -24.36% |
| 2011-12-31 | -150.84% |
| 2011-09-30 | -39.04% |
| 2011-06-30 | -41.50% |
| 2011-03-31 | -29.47% |
| 2010-12-31 | -24.55% |
| 2010-09-30 | -28.24% |
| 2010-06-30 | -14.45% |
| 2010-03-31 | -11.62% |
| 2009-12-31 | -83.94% |
| 2009-09-30 | -8457.80% |
| 2009-06-30 | -14775.95% |
| 2009-03-31 | -4047.71% |
| 2008-12-31 | -6966.66% |
| 2008-09-30 | -7532.75% |
| 2008-06-30 | -9922.35% |
| 2008-03-31 | -361820.06% |
| 2007-12-31 | -1473.93% |
| 2007-09-30 | -34323.26% |
| 2007-06-30 | -32349.58% |
| 2007-03-31 | -3236.00% |
| 2006-12-31 | -6340.50% |
| 2006-09-30 | -14636.59% |
| 2006-06-30 | -15336.41% |
| 2006-03-31 | -13828.65% |
| 2005-12-31 | -6939.27% |
| 2005-09-30 | -6591.06% |
| 2005-06-30 | -3761.91% |
| 2005-03-31 | -1955.50% |
| 2004-12-31 | -2271.26% |
| 2004-09-30 | -13925.94% |
| 2004-06-30 | -5836.84% |
| 2004-03-31 | -1392.39% |
| 2003-12-31 | -2576.38% |
| 2003-09-30 | -1285.28% |
| 2003-06-30 | -1203.54% |
| 2003-03-31 | -685.94% |
| 2002-12-31 | -534.58% |
| 2002-09-30 | -1125.59% |
